• Search
  • Helpdesk
  • Sales contact
Get your demo

Webcast

Rethinking Phase 1 Oncology Trials with Electronic Patient-Reported Outcomes

OncologyPRO
The primary aim of Phase 1 oncology clinical trials is to determine the safety of a new treatment, and to establish the Recommended Phase 2 Dose (RP2D), which is often...

The critical importance of Patient Reported Outcomes (PROs) for Emerging Biopharma Companies

biotechPRO
In today’s competitive landscape, biotech and emerging biopharma companies (EBPs) must demonstrate the value of their innovations early and convincingly....

Empowering patients through data: a collaborative vision of clinical data management

Data management
In the ever-evolving landscape of clinical trials, the importance of patient-centric approaches and effective data management cannot be overstated. This...

How to improve the collaboration between expert patients and healthcare companies?

Patients insights
Why and how could the partnerships between expert patients and healthcare companies be improved?In this insightful interview, Françoise Sellin, a...

“Dealing with multiple data sources in clinical trials” webcast

Data management
Dealing with multiple data sources:Fundamental aspects of data integration and reconciliation for high data qualityAs technology's penetration in the clinical...

Working with patient associations: What is the key to a positive interaction?

Patients insightsRare disease
What rare disease patients and families want is a simpler life.Discover here what makes the relationship between the members of...

How a patient association gave rise to a company

Patients insightsRare disease
A patient association in rare diseases is first and foremost families who all have one thing in common: they need...

Easing site and patient burden: How interoperability and an integrated experience work together

Interoperability
Technology is becoming increasingly woven into our daily lives, and the world of clinical trials is no exception: penetration of...

Working in collaboration with patient associations: insights from Estelle Haenel, Kayentis Medical Director

Patients insights
Whilst we hear a lot about working in collaboration with patient representatives, not so many industrial stakeholders are actually doing...

“Get ready for fully remote eCOA in your next DCT trial” webcast

Data management
Are you ready for fully remote eCOA in your next DCT trial?Learn how to build a better plan for Data...

“DCT is not the goal, just the means” webinar

Decentralized trials
Using technology to add flexibility to clinical trials can support patients and sites – but a thoughtful consideration of the...

Do we really know what clinical trial patients need?

Patients insights
Let’s challenge our beliefs: Do we really know what clinical trial patients need? Do we have the right understanding of...
Follow us on social media
Subscribe to our newsletter
You may also like

ePRO in early phase oncology trials: A revolution on the...

Patient-Reported Outcomes in early-phase oncology clinical trialsA Stepping Stone to...

Answering the Sustainability Call: Digital Health Technologies and eCOA

Kayentis secures Silver Medal in EcoVadis sustainability evaluation with significant...

Engage patients throughout the clinical trial journey

Rethinking Phase 1 Oncology Trials with Electronic Patient-Reported Outcomes

About the author
Picture of Marc Chaperon

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.